TCT-265 One-year Outcome of Polymer-free Amphilimus-eluting Stent versus Biodegradable Polymer Biolimus-eluting Stent in Diabetes Mellitus Patients. Propensity-Matched Analysis of the ASTUTE (AmphilimuS iTalian mUlticenTre rEgistry) and INSPIRE-1 (Italian Nobori Stent ProspectIve REgistry-1) Registries

Background Patients with diabetes mellitus (DM) remain at higher risk for stent restenosis and adverse cardiovascular events, even in the drug-eluting stent era.

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 68; no. 18; p. B108
Main Authors Godino, Cosmo, Pivato, Carlo Andrea, Chiarito, Mauro, donahue, michael, Testa, Luca, Parenti, Dennis Zavalloni, Rutigliano, David, lucisano, luigi, Viani, Giacomo Maria, Locuratolo, Nicola, monello, alberto, parisi, rosario, colantonio, riccardo, Regazzoli, Damiano, Palloshi, Altin, Milazzo, Diego, Aprigliano, Gianfranco, Nicolino, Annamaria, Caramanno, Giuseppe, Moshiri, Shahram, fattori, rossella, Sardella, Gennaro, Cappelletti, Alberto, Montorfano, Matteo, Presbitero, Patrizia, Bedogni, Francesco, Briguori, Carlo, Manzan, Erica, Colombo, Antonio
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.11.2016
Elsevier Limited
Subjects
Cardiology
Cardiovascular
Diabetes
Internal Medicine
Polymers
Stents
Online AccessGet full text

Cover

More Information
Summary:Background Patients with diabetes mellitus (DM) remain at higher risk for stent restenosis and adverse cardiovascular events, even in the drug-eluting stent era.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2016.09.394